trending Market Intelligence /marketintelligence/en/news-insights/trending/M36f_qM7O9lVuFbKCWzoNg2 content esgSubNav
In This List

Agios Pharmaceuticals chief commercial officer joins Ignyta board

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Agios Pharmaceuticals chief commercial officer joins Ignyta board

Ignyta Inc. added Agios Pharmaceuticals Chief Commercial Officer Steven Hoerter to its board as an independent director.

Hoerter will also be a member of the nominating and corporate governance committee. He previously served as executive vice president and chief commercial officer at Clovis Oncology Inc.

His appointment expands Ignyta's board to six members from five.